Hybrid polypeptides with selectable properties
The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-rel...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Levy Odile Esther Soares Christopher J D'Souza Lawrence J Lewis Diana Y Ghosh Soumitra S Hanley Michael R Parkes David G Mack Christine M Jodka Carolyn M |
| description | The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9453063B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9453063B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9453063B23</originalsourceid><addsrcrecordid>eNrjZNDzqEwqykxRKMjPqSxILSjJTEktVijPLMlQKE7NSU0uSUzKSVUoKMovSC0qyUwt5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBliamxgZmxk5GxkQoAQD1oSsE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Hybrid polypeptides with selectable properties</title><source>esp@cenet</source><creator>Levy Odile Esther ; Soares Christopher J ; D'Souza Lawrence J ; Lewis Diana Y ; Ghosh Soumitra S ; Hanley Michael R ; Parkes David G ; Mack Christine M ; Jodka Carolyn M</creator><creatorcontrib>Levy Odile Esther ; Soares Christopher J ; D'Souza Lawrence J ; Lewis Diana Y ; Ghosh Soumitra S ; Hanley Michael R ; Parkes David G ; Mack Christine M ; Jodka Carolyn M</creatorcontrib><description>The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160927&DB=EPODOC&CC=US&NR=9453063B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160927&DB=EPODOC&CC=US&NR=9453063B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Levy Odile Esther</creatorcontrib><creatorcontrib>Soares Christopher J</creatorcontrib><creatorcontrib>D'Souza Lawrence J</creatorcontrib><creatorcontrib>Lewis Diana Y</creatorcontrib><creatorcontrib>Ghosh Soumitra S</creatorcontrib><creatorcontrib>Hanley Michael R</creatorcontrib><creatorcontrib>Parkes David G</creatorcontrib><creatorcontrib>Mack Christine M</creatorcontrib><creatorcontrib>Jodka Carolyn M</creatorcontrib><title>Hybrid polypeptides with selectable properties</title><description>The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDzqEwqykxRKMjPqSxILSjJTEktVijPLMlQKE7NSU0uSUzKSVUoKMovSC0qyUwt5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8aHBliamxgZmxk5GxkQoAQD1oSsE</recordid><startdate>20160927</startdate><enddate>20160927</enddate><creator>Levy Odile Esther</creator><creator>Soares Christopher J</creator><creator>D'Souza Lawrence J</creator><creator>Lewis Diana Y</creator><creator>Ghosh Soumitra S</creator><creator>Hanley Michael R</creator><creator>Parkes David G</creator><creator>Mack Christine M</creator><creator>Jodka Carolyn M</creator><scope>EVB</scope></search><sort><creationdate>20160927</creationdate><title>Hybrid polypeptides with selectable properties</title><author>Levy Odile Esther ; Soares Christopher J ; D'Souza Lawrence J ; Lewis Diana Y ; Ghosh Soumitra S ; Hanley Michael R ; Parkes David G ; Mack Christine M ; Jodka Carolyn M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9453063B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Levy Odile Esther</creatorcontrib><creatorcontrib>Soares Christopher J</creatorcontrib><creatorcontrib>D'Souza Lawrence J</creatorcontrib><creatorcontrib>Lewis Diana Y</creatorcontrib><creatorcontrib>Ghosh Soumitra S</creatorcontrib><creatorcontrib>Hanley Michael R</creatorcontrib><creatorcontrib>Parkes David G</creatorcontrib><creatorcontrib>Mack Christine M</creatorcontrib><creatorcontrib>Jodka Carolyn M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Levy Odile Esther</au><au>Soares Christopher J</au><au>D'Souza Lawrence J</au><au>Lewis Diana Y</au><au>Ghosh Soumitra S</au><au>Hanley Michael R</au><au>Parkes David G</au><au>Mack Christine M</au><au>Jodka Carolyn M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Hybrid polypeptides with selectable properties</title><date>2016-09-27</date><risdate>2016</risdate><abstract>The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US9453063B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Hybrid polypeptides with selectable properties |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Levy%20Odile%20Esther&rft.date=2016-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9453063B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |